Apr 23 |
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
|
Apr 22 |
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
|
Apr 17 |
Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be Sustainable
|
Apr 15 |
Recent 3.8% pullback isn't enough to hurt long-term Krystal Biotech (NASDAQ:KRYS) shareholders, they're still up 437% over 5 years
|
Apr 4 |
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting
|
Apr 1 |
Recent Price Trend in Krystal Biotech (KRYS) is Your Friend, Here's Why
|
Mar 27 |
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
|
Mar 14 |
Krystal Biotech, Inc. (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why
|
Mar 13 |
(KRYS) - Analyzing Krystal Biotech's Short Interest
|
Mar 8 |
Can Krystal Biotech, Inc. (KRYS) Run Higher on Rising Earnings Estimates?
|